BG60450B2 - Фармацевтичен състав - Google Patents

Фармацевтичен състав Download PDF

Info

Publication number
BG60450B2
BG60450B2 BG52984A BG5298481A BG60450B2 BG 60450 B2 BG60450 B2 BG 60450B2 BG 52984 A BG52984 A BG 52984A BG 5298481 A BG5298481 A BG 5298481A BG 60450 B2 BG60450 B2 BG 60450B2
Authority
BG
Bulgaria
Prior art keywords
water
guanine
composition according
hydroxyethoxymethyl
ester
Prior art date
Application number
BG52984A
Other languages
Bulgarian (bg)
English (en)
Inventor
Trevor Jones
Alan White
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26276273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG60450(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of BG60450B2 publication Critical patent/BG60450B2/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG52984A 1980-07-18 1981-07-17 Фармацевтичен състав BG60450B2 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18
GB8033218A GB2080106B (en) 1980-07-18 1980-10-15 Acyclovin preparations

Publications (1)

Publication Number Publication Date
BG60450B2 true BG60450B2 (bg) 1995-04-28

Family

ID=26276273

Family Applications (1)

Application Number Title Priority Date Filing Date
BG52984A BG60450B2 (bg) 1980-07-18 1981-07-17 Фармацевтичен състав

Country Status (30)

Country Link
EP (1) EP0044543B1 (fr)
AR (1) AR225680A1 (fr)
AT (1) AT381025B (fr)
AU (1) AU547391B2 (fr)
BG (1) BG60450B2 (fr)
CA (1) CA1172169A (fr)
CS (1) CS229674B2 (fr)
CY (1) CY1309A (fr)
DD (1) DD203464A5 (fr)
DE (1) DE3163982D1 (fr)
DK (1) DK149191C (fr)
ES (1) ES8305363A1 (fr)
FI (1) FI76255C (fr)
GB (1) GB2080106B (fr)
GR (1) GR75104B (fr)
HK (1) HK95485A (fr)
HU (1) HU185936B (fr)
IE (1) IE51120B1 (fr)
IL (1) IL63351A (fr)
IT (1) IT1171399B (fr)
MC (1) MC1408A1 (fr)
MY (1) MY8600389A (fr)
NO (1) NO155038C (fr)
NZ (1) NZ197744A (fr)
PH (1) PH16308A (fr)
PL (1) PL135416B1 (fr)
PT (1) PT73391B (fr)
RO (1) RO82678A (fr)
SG (1) SG72085G (fr)
ZW (1) ZW17181A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095813A3 (fr) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Compositions pharmaceutiques topiques pénétrantes contenant la 9-(2-hydroxyéthoxyméthyl)-guanine
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
DE69313895T2 (de) * 1992-03-20 1998-02-12 Unichema Chemie Bv Formtrennzusammensetzung
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
AU2036297A (en) * 1996-03-20 1997-10-10 Glaxo Group Limited Topical formulations of aciclovir
GB9611167D0 (en) * 1996-05-29 1996-07-31 Glaxo Group Ltd Medicaments
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
ATE396732T1 (de) * 2004-04-05 2008-06-15 Liomont S A De C V Lab Neue antivirale pharmazeutische zusammensetzung
EP2005824A1 (fr) † 2007-06-21 2008-12-24 Bayer CropScience AG Suspensions d'agents actifs dans de la glycérine
WO2017029298A1 (fr) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. Composition antivirale topique

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4141976A (en) * 1976-01-05 1979-02-27 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Also Published As

Publication number Publication date
MY8600389A (en) 1986-12-31
CA1172169A (fr) 1984-08-07
ES504046A0 (es) 1983-04-01
PH16308A (en) 1983-09-05
NO812464L (no) 1982-01-19
HK95485A (en) 1985-12-06
GR75104B (fr) 1984-07-13
FI812257L (fi) 1982-01-19
CS229674B2 (en) 1984-06-18
MC1408A1 (fr) 1982-07-16
IL63351A0 (en) 1981-10-30
ES8305363A1 (es) 1983-04-01
AT381025B (de) 1986-08-11
HU185936B (en) 1985-04-28
PT73391B (en) 1983-06-15
AU547391B2 (en) 1985-10-17
PL232259A1 (en) 1983-07-04
DE3163982D1 (en) 1984-07-12
SG72085G (en) 1986-05-02
IT8148925A0 (it) 1981-07-17
IE51120B1 (en) 1986-10-01
FI76255C (fi) 1990-03-14
DK149191B (da) 1986-03-10
AU7307381A (en) 1982-01-21
IE811617L (en) 1982-01-18
ATA318081A (de) 1986-01-15
FI76255B (fi) 1988-06-30
ZW17181A1 (en) 1983-02-23
EP0044543A1 (fr) 1982-01-27
PT73391A (en) 1981-08-01
NO155038C (no) 1987-02-04
AR225680A1 (es) 1982-04-15
IL63351A (en) 1983-10-31
DK149191C (da) 1986-09-08
GB2080106A (en) 1982-02-03
CY1309A (en) 1985-12-06
IT1171399B (it) 1987-06-10
GB2080106B (en) 1984-03-07
DD203464A5 (de) 1983-10-26
PL135416B1 (en) 1985-10-31
RO82678A (fr) 1984-05-23
NZ197744A (en) 1983-05-10
DK321681A (da) 1982-01-19
NO155038B (no) 1986-10-27
EP0044543B1 (fr) 1984-06-06

Similar Documents

Publication Publication Date Title
BG60450B2 (bg) Фармацевтичен състав
NL193419C (nl) Topicaal toepasbare farmaceutische samenstellingen.
US4963555A (en) Formulations of heterocyclic compounds
JP3947215B2 (ja) 安定な局所レチノイド組成物
KR920021139A (ko) 약학 조성물
EP0662819B1 (fr) Emulsion pharmaceutique d'huile dans l'eau a action antivirale contenant de la 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) ou un sel ou ester de ladite substance
EP0471084B1 (fr) Composition d'emulsion aqueuse contenant un analgesique anti-inflammatoire steroidien
US7223387B2 (en) Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
AP197A (en) Pharmaceutical formulations for treatment of virus infections of the skin containing penciclovir.
CA2351463C (fr) Formulations antivirales renfermant du propylene glycol et un ester acide alkanoique d'isopropyle
PT100670B (pt) Formulacoes farmaceuticas topicas de oleo-em -agua ou aquosa para o tratamento de infeccoes virais
JPH0699304B2 (ja) ３―オキシゲルミルプロピオン酸を有効成分とする外用剤
WO1997045123A1 (fr) Formulations pharmaceutiques topiques comprenant de l'aciclovir
WO1993015716A1 (fr) Formulation a verser directement, a base de levamisole ou de tetramisole
JPH07238021A (ja) 皮膚刺激作用のない製薬用軟膏及びその製造方法
JPS5931709A (ja) ９−（２−ヒドロキシエトキシメチル）グアニンを含有する浸透性局所製薬組成物
TH181A (th) การจัดสูตรผสมของสารประกอบเฮเทอโรไซลิค